Skip to main content

Google vs Roche: Revenue, Profit and Business Model

Google reported $402.8B of revenue in FY2025 and $132.2B of net income. Roche reported ~$76B of revenue in FY2025 and ~$15.5B of net income.

Latest financial snapshot

Google

Latest revenue
$402.8B (FY2025)
Net income
$132.2B
Net margin
32.8%
Revenue growth
+18.1% a year, FY2016–FY2025

Roche

Latest revenue
~$76B (FY2025)
Net income
~$15.5B
Net margin
20.3%
Revenue growth
-1.0% a year, FY2021–FY2025

Financial summary

Google

Alphabet's FY2025 Form 10-K reported $402.836 billion of revenue and $132.170 billion of net income, making it one of the most profitable companies in the world. Growth accelerated in 2026: Q2 2026 revenue rose 24% year over year to $119.8 billion, operating income rose 30% to $40.8 billion and operating margin reached 34.0%. Reported Q2 net income of $112.1 billion was inflated by a $99.0 billion gain, mostly unrealized gains on equity holdings, so operating income is the cleaner measure. The trade-off is spending: management raised 2026 capital expenditure guidance to $195-205 billion, and analysts flagged negative free cash flow in Q2 2026 as data-center investment outpaced operating cash flow.

Roche

Roche's 2025 group sales were ~$73.8 billion (CHF 61.5 billion), up 7% at constant exchange rates but only 2% in Swiss francs. Core operating profit grew 13% CER to ~$26.2 billion (CHF 21.8 billion), core EPS was CHF 19.46, and IFRS net income jumped to ~$16.6 billion (CHF 13.8 billion) from ~$11 billion (CHF 9.2 billion) in 2024, when impairments depressed profit. In H1 2026 core operating margin widened 1.7 points to 39.0%, while a strong franc pushed reported sales down 2%. The board raised the dividend to CHF 9.80, the 39th consecutive increase, and guided for mid-single-digit CER sales growth and high-single-digit core EPS growth in 2026.

Revenue and profit by year

Google

Google revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025$402.8B$132.2B32.8%+15.1%Source
FY2024$350B$100.1B28.6%+13.9%Source
FY2023$307.4B$73.8B24.0%+8.7%Source
FY2022$282.8B$60B21.2%+9.8%Source
FY2021$257.6B$76B29.5%+41.2%Source
FY2020$182.5B$40.3B22.1%+12.8%Source
FY2019$161.9B$34.3B21.2%+18.3%Source
FY2018$136.8B$30.7B22.5%+23.4%Source
FY2017$110.9B$12.7B11.4%+22.8%Source
FY2016$90.3B$19.5B21.6%—Source
Full Google financials

Roche

Roche revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025~$76B~$15.5B20.3%+1.5%Source
FY2024~$74.9B~$9.9B13.3%+3.2%Source
FY2023~$72.5B~$13.8B19.0%-8.2%Source
FY2022~$79B~$14.9B18.9%-0.1%Source
FY2021~$79B~$16.7B21.2%—Source
Full Roche financials

Where the revenue comes from

Google

  • Google Search advertising~12%

    Auction-based text and shopping ads served alongside organic search results, generating approximately $198 billion in FY2024 through cost-per-click and cost-per-impression pricing.

  • YouTube advertising~12%

    Video advertising across pre-roll, mid-roll, display, and Shorts formats, plus subscription revenue from YouTube Premium, Music, and YouTube TV, totaling approximately $36 billion in ad revenue for FY2024.

  • Google Cloud~12%

    Infrastructure-as-a-service, platform tools, Vertex AI, BigQuery, Mandiant cybersecurity, and Google Workspace subscriptions, generating significant FY2025 revenue.

  • Google Network~12%

    Ads placed on third-party websites through AdSense, AdMob, and Google Ad Manager, generating approximately $31 billion in FY2024 with revenue shared with publishers.

  • Other Bets~12%

    Revenue from Waymo autonomous ride-hailing, Verily health technology, hardware sales (Pixel, Nest, Fitbit), Google Play commissions, and other non-advertising sources.

Roche

  • Prescription medicines
  • Biologics and oncology drugs
  • Diagnostic instruments
  • Diagnostic reagents and tests
  • Sequencing and molecular diagnostics
  • Clinical data and companion diagnostics

Business model and strategy

Google

How it makes money

Alphabet makes money mainly by selling ads against user intent and attention. Google Search & other, YouTube ads and the Google Network together account for roughly three quarters of revenue. Advertisers bid in real-time auctions to appear next to queries or videos, and Google charges per click, view or conversion.

Growth strategy

Alphabet's growth plan has four parts: put Gemini into Search (AI Overviews and AI Mode), Workspace, Android and Chrome to keep users and advertisers engaged; sell AI infrastructure, TPUs and Gemini models through Google Cloud, backed by the Wiz security platform acquired in March 2026; grow subscriptions such as YouTube Premium, YouTube TV and Google One AI plans;

Competitive advantage

Alphabet's edge is a stack few rivals own end to end: default distribution through Android and Chrome, the largest pool of search-intent data, YouTube's video audience, its own TPU chips and global data centers, and frontier models from Google DeepMind.

Google business model in full

Roche

How it makes money

Roche makes money in two ways. The Pharmaceuticals Division (~$57.2 billion (CHF 47.7 billion) in 2025) sells patented medicines, mostly biologics, in oncology, neuroscience, immunology, ophthalmology and haemophilia; top growth drivers in 2025 were Phesgo, Xolair, Ocrevus, Hemlibra and Vabysmo.

Growth strategy

Roche is building a cardiovascular, renal and metabolic franchise through acquisitions of Carmot Therapeutics (2023, $2.7 billion upfront) and 89bio (2025, up to about $3.5 billion), the petrelintide partnership with Zealand Pharma, and a new Innovation Center in Boston opened in September 2026.

Competitive advantage

Roche's edge comes from three things: scale in both drugs and diagnostics, a long-horizon ownership structure, and a federated R&D model. The Hoffmann and Oeri family pool holds the majority of voting shares, which shields management from takeover pressure.

Roche business model in full

Questions about Google vs Roche

Which company has higher revenue — Alphabet Inc. or F. Hoffmann-La Roche AG?

Alphabet Inc. reported $402.8B (FY2025), while F. Hoffmann-La Roche AG reported ~$76B (FY2025). By last reported revenue, Alphabet Inc. is the larger business, with F. Hoffmann-La Roche AG reporting a smaller revenue base.

What is the market cap of Alphabet Inc. vs F. Hoffmann-La Roche AG?

Alphabet Inc.'s market capitalisation stands at $4.31T, while F. Hoffmann-La Roche AG's is $355.0B. Alphabet Inc. carries the higher market valuation, reflecting investors' expectations of its future earnings power relative to F. Hoffmann-La Roche AG.

Which is more financially efficient — Alphabet Inc. or F. Hoffmann-La Roche AG?

Alphabet Inc. generates $2.11M / employee in revenue per employee, while F. Hoffmann-La Roche AG generates $674k / employee. Alphabet Inc. shows higher revenue efficiency per headcount, though this reflects business model differences — capital-light software companies routinely outperform labour-intensive manufacturers on this metric.

How do Alphabet Inc. and F. Hoffmann-La Roche AG make money?

Alphabet Inc. and F. Hoffmann-La Roche AG generate revenue in fundamentally different ways. Alphabet Inc.: Alphabet makes money mainly by selling ads against user intent and attention. F. Hoffmann-La Roche AG: Roche makes money in two ways.

Which company is valued higher relative to revenue — Alphabet Inc. or F. Hoffmann-La Roche AG?

On a price-to-sales (P/S) basis, Alphabet Inc. trades at 10.7x P/S and F. Hoffmann-La Roche AG at 4.7x P/S. Alphabet Inc. commands a higher revenue multiple, typically indicating that investors expect faster growth or higher future margins compared to F. Hoffmann-La Roche AG. A higher multiple is not inherently better — it may also signal that the stock is priced for perfection.

Is Alphabet Inc. bigger than F. Hoffmann-La Roche AG?

By last reported revenue, Alphabet Inc. ($402.8B (FY2025)) is the larger company compared to F. Hoffmann-La Roche AG (~$76B (FY2025)). Revenue scale is one dimension of size — market capitalisation, employee count, and geographic reach are also relevant depending on the context.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Google vs Roche overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.